Okamoto S, Wanaka K, Hijikata-Okunomiya A, Okada Y, Katsuura Y
Kobe Research Projects on Thrombosis and Haemostasis, Japan.
Agents Actions Suppl. 1992;38 ( Pt 1):198-205. doi: 10.1007/978-3-0348-7321-5_26.
We found a novel and highly selective synthetic inhibitor of plasma kallikrein (PK), called PKSI-527; the Ki value was 0.81 microM. PKSI-527 inhibited the bradykinin (BK) generation induced by kaolin and prolonged partial thromboplastin time (PTT). PKSI-527 prevented the decrease of fibrinogen (Fg) levels due to i.v. injection of ellagic acid in mice and ameliorated the endotoxin (ET)-induced DIC in rats.